Assembly Biosciences Inc ASMB

US Biotechnology

$21.18 ▼ -2.80% ($-0.61)

🔥 High Short Interest

Open $21.65

Prev Close $21.79

Day Range $20.77 – $21.70

52W Range $19.20 – $39.71

Market Cap $443.66M

Beta 1.24

EPS (TTM) $-0.16

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2010-12-17
Shares Out.	20,360,000
Website	assemblybio.com/ ↗
Phone	18009279800
Employees	73
Revenue	$13.4M
Gross Profit	$13.4M
Net Income	-$3.9M
Free Cash Flow	-$38.6M
Total Assets	$330.8M
Total Liabilities	$25.2M
Equity	$305.6M

About Assembly Biosciences Inc

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Assembly Biosciences Inc is a publicly traded company under the ticker symbol ASMB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.